a2 Collective Leadership

The a2 Collective represents the Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program funded by the National Institute on Aging (NIA), part of the National Institutes of Health. The a2 Collective comprises three AITCs centered at Johns Hopkins University (JH AITC), the University of Massachusetts Amherst (MassAITC), and the University of Pennsylvania (PennAITech) and the a2 Collective Coordinating Center managed by Rose Li & Associates, Inc. (RLA).

Rose Li, PhD, MBA

Principal Investigator

Stephen C. Liu, MBA

Managing Director
Marketing/Business Development

Kayla Harr, PhD

Project Coordinator
Strategic Communications

Rob Verhein, MA

Project Coordinator
Pilot Competitions

Cecelia Garcia, PhD

Research Coordinator
Analytics

Kelli Rae Goggans, PhD

Research Coordinator
Science Policy

Sofia Jones

Event Manager

Amanda Curran

Sponsorship Administrator

Research Collaboratories

Learn more about each AITC’s team by visiting their website below:

Partha Bhattacharyya, PhD

AITC Program Official
Program Director
Division of Behavioral and Social Research

Dinesh John, PhD

AITC Project Scientist
Program Advisor
Division of Behavioral and Social Research

Rebecca Krupenevich, PhD

AITC Project Scientist
Health Scientist/AAAS Science & Technology Policy Fellow
Division of Behavioral and Social Research

External Advisory Panel

Cansu Canca, PhD
Founding Director, AI Ethics Lab
Research Associate Professor and Ethics Lead, Institute for Experiential AI, Northeastern University
Winn Hong, MBA, MS
Deputy Executive Director, Alfred E. Mann Institute for Biomedical Engineering, University of Southern California
Susann Keohane, MS
Global Research Leader for the Aging Initiative, IBM
Chaiwoo Lee, PhD
Research Scientist, MIT AgeLab
Hon Pak, MD, MBA
Chief Medical Officer, Samsung Electronics America
Diane Ty, MA, MBA
Senior Director, Center for the Future of Aging, Milken Institute
Senior Advisor, Business for Impact, McDonough School of Business, Georgetown University
Alex Zhavoronkov, PhD
Founding CEO, Insilico Medicine